DualEntry | $90,000,000 | (Oct 7, 2025)
Voltai | $1,311,818 | (Oct 7, 2025)
NanoPhoria | $97,716,710 | (Oct 7, 2025)
Certified by Founder
Lodge
Pathalys Pharma
start up
United States
- Raleigh, North Carolina
- 07/02/2023
- Unknown
- $150,000,000
Pathalys Pharma is a private, late-stage clinical biopharmaceutical company committed to the development of advanced therapeutics that address unmet needs in the management of late-stage chronic kidney disease (CKD). Pathalys was created in partnership with Catalys Pacific and DaVita to become a multi-asset pharmaceutical company focused on the needs of patients with end-stage renal disease.
- Industry Biotechnology Research
- Website https://pathalys.com/
- LinkedIn https://www.linkedin.com/company/pathalys/
Trogenix | $94,323,600 | (Oct 7, 2025)
SafeHill | $2,600,000 | (Oct 7, 2025)
Moonlake AI | $28,000,000 | (Oct 7, 2025)
Ansa Biotechnologies, Inc. | $54,400,000 | (Oct 7, 2025)
kiutra | $15,206,295 | (Oct 7, 2025)
Bee Maps (Powered by Hivemapper) | $32,000,000 | (Oct 7, 2025)
Cookiy AI | $7,000,000 | (Oct 7, 2025)
Cirrus Therapeutics | $11,000,000 | (Oct 7, 2025)
Hupside | $1,700,000 | (Oct 2, 2025)